Molecular and Translational Research of the Microbiome in Infectious and Non-infectious Diseases
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Microbiology in Human Health and Disease".
Deadline for manuscript submissions: closed (31 October 2022) | Viewed by 29578
Special Issue Editor
Interests: microbiome; disease prevention; systems biology; nutraceuticals (prebiotic and probiotics); immune protection; developmental programming; anti-aging/healthspan; food and drug toxicity
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The human microbiome provides the vast majority of genes, significant metabolic capacity, and exquisite physiological regulation of the human holobiont. As such, it is the starting point for determining risk of both infectious and non-infectious disease (NCDs). This special issue welcomes both original research and review articles and is divided into two interlinked parts. The first part involves research into the molecular pathways that determine microbiome dysbiosis and/or those that connect the dysbiosis with systems biology dysfunction. The second part deals with translation of microbiome-host systems interactions that lead us toward effective disease prevention and/or cures of infectious or noninfectious diseases (e.g., NCDs.)
Prof. Dr. Rodney R. Dietert
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- microbiome
- metabolomics
- molecular pathways
- biomedicines
- systems biology
- infectious diseases
- noncommunicable diseases
- disease prevention and treatment
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.